LEADER 03467nam  2201093z- 450 
001 9910566458203321
005 20231214133153.0
035   $a(CKB)5680000000037799
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/80955
035   $a(EXLCZ)995680000000037799
100   $a20202205d2022      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBiomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management
210   $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 electronic resource (208 p.)
311   $a3-0365-3746-5 
311   $a3-0365-3745-7 
330   $aThis Special Issue contributes original research and review articles on the role of new protein, molecular, and genetic markers used for the diagnosis and progression of civilization diseases, as well as biomarkers useful in the monitoring the effects of the implemented treatment.
606   $aMedicine$2bicssc
610   $apharmacogenomics
610   $aNGS variants
610   $apersonalized medicine
610   $aFSHR
610   $apersonalized drug therapy
610   $ahedgehog-interacting protein
610   $aimpaired fasting glucose
610   $aimpaired glucose tolerance
610   $anewly diagnosed diabetes
610   $anormal glucose tolerance
610   $ainflammatory bowel disease
610   $aulcerative colitis
610   $aCrohn?s disease
610   $aextracellular matrix components
610   $ahyaluronan
610   $ainflammatory bowel diseases (IBD)
610   $aCrohn?s disease (CD)
610   $aulcerative colitis (UC)
610   $asulfated glycosaminoglycans (sGAG)
610   $ahyaluronan (HA)
610   $asoluble part of syndecan-1 (sCD138)
610   $amicroRNA
610   $acardiovascular disease
610   $adiabetes
610   $amortality
610   $aantiplatelet therapy
610   $aplatelet reactivity
610   $aLet-7e
610   $amiR-126
610   $amiR-223
610   $amiR-125a-3p
610   $aCCL11
610   $aCCL24
610   $aCCL26
610   $aCCR3
610   $aCRC
610   $aadiponectin
610   $aadipokines
610   $arheumatology
610   $aobesity
610   $aoverweight
610   $acase control study
610   $arheumatoid arthritis
610   $aTNF-? inhibitors
610   $abone turnover markers
610   $aPINP
610   $aPICP
610   $aNTX-I
610   $aCTX-I
610   $aRANKL/OPG
610   $aovarian cancer
610   $ainterleukin 21
610   $ainterleukin 22
610   $alymphocytes
610   $amacrophages
610   $adendritic cells
610   $ainnate lymphoid cells
610   $abreast cancer
610   $aextracellular matrix
610   $aproteins
610   $atumorigenesis
610   $atumor microenvironment
615  7$aMedicine
700   $aKomosinska-Vassev$b Katarzyna$4edt$01319548
702   $aOlczyk$b Pawel$4edt
702   $aKomosinska-Vassev$b Katarzyna$4oth
702   $aOlczyk$b Pawel$4oth
906   $aBOOK
912   $a9910566458203321
996   $aBiomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management$93033952
997   $aUNINA